Pfizer says its COVID-19 vaccine safe and effective for children ages 5 to 11

Drugmaker Pfizer announced Monday that its COVID-19 vaccine was safe, well-tolerated and had a "robust antibody response" in its pediatric trial for children ages 5 through 11.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines